Regencell's stock soared 17,000% fueled by speculation, despite no revenue or clinical progress. Read why I think the RGC ...

Urinalysis is the oldest laboratory test ever performed. It is a fast, easy, low-cost test for a variety of clinical ...

Q4 2024 Earnings Call Transcript May 29, 2025 Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.22 ...

Guard Therapeutics today announced that an independent Data Safety Monitoring Committee (DSMC) has completed the second and final planned review of safety data from the ongoing Phase 2b clinical trial ...

Yet, I assess that Viking Therapeutics’s main growth vector will likely be imputed to its ability to commercialize and ...

In the study, "Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder: The UNITE Randomized Clinical Trial," published in JAMA Neurology, researchers ...

The first two patients were dosed on May 12 th, at the Radboud University Medical Center in Nijmegen, Netherlands, where the Phase 2 clinical trial has been activated and is currently screening ...

Q1 2025 Earnings Call Transcript May 11, 2025 Operator: Greetings, and welcome to KORU Medical Systems First Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this ...

Lupus has only three approved treatments compared to over 30 for rheumatoid arthritis, due to enrollment challenges in clinical trials. Altruism and personal benefit motivate trial participation ...

Share on Pinterest Wegovy resolved liver inflammation in nearly two-thirds of participants in a major clinical trial, twice the rate seen with placebo. Steve Christo-Corbis/Getty Images Wegovy ...

A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca's long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential ...

IRVINE, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today provided a positive update on its substantial progress toward ...